Share
 
Title
Presenter
Authors
Institutions

Background: The ultimate success of antiretroviral therapy (ART) initiation is dependent on achievement of high retention and adherence. Data are needed on factors that influence retention of ART patients in resource-limited settings.
Methods: We evaluated 12-month retention (PEPFAR MER indicator) among ART patients at PEPFAR-funded, ICAP-supported health facilities (HF) in Côte d''Ivoire (CI) and Swaziland (SW). By country, proportions of retained ART patients were calculated for quarterly cohorts initiating ART from January 2014-September 2015. Poisson regression models with generalized estimating equations (GEE) were used to examine time trends and significant demographic and HF factors associated with retention.
Results: Data from 6,923 HIV patients from CI (87 HF) and 19,118 from SW (93 HF) who initiated ART in this period were included in the analysis. In CI, 71.4% of patients were women and 94.2% were >15 years. Retention in CI at 12-months increased from 74.4% for the first cohort (January-March 2014) to 88.8% for the last cohort (July-September 2015), an average increase of 2.6 % per quarter after adjusting for sex, age and facility type (ptrend< 0.001). Men had lower retention than women (p< 0.0001). Patients at secondary (p< 0.0001) or tertiary (p=0.02) HF had lower retention than those at primary HF. In SW, 66.2% of patients were women and 94.3% were >15 years old. The 12-month retention was 92.7% for the first cohort and 88.2% for the last cohort, with no significant change over time (ptrend=0.34). Children 5-14 years old (p=0.001) had higher retention than adults ³15 years but children < 5 years did not (p=0.69). Patients at semi-urban HF (p=0.02) had higher retention than urban HF, while those at tertiary HF (p=0.04) had lower retention compared to primary HF.
Conclusions: Retention on ART was high in both countries compared to earlier reports from sub-Saharan Africa, with differences noted by sex, age and HF location and type. Overall, these findings are encouraging and bode well for achieving the individual and societal benefits of ART. Viral load data are needed to confirm this potential.


  Côte d''IvoireSwaziland
  Patients enroled% retainedRR ratio(95% CI)Adj.RR ratio(95%CI)Patients enrolled% retainedRR ratio(95%CI)adj. RR ratio(95%CI)
Total 6,92379.8  19,11890.9  
Sex:Male / Female1,978/ 4,94576.3 / 81.2ref 1.05(1.03,1.1)^ref 1.06(1.03,1.1)^6,468/ 12,65090.2 / 91.3ref. 1.01(0.99,1.03) 
Age<5 yrs / 5-14 yrs/ >=15 yrs147 / 256 / 6,52076.9 / 78.5 / 79.90.97(0.88,1.07) 1.01(0.94,1.08) ref0.97(0.89,1.07) 1.0(0.94,1.08) ref523 / 566 / 18,02989.3 / 96.3 / 90.81.01(0.95,1.07) 1.1(1.03,1.15)^ ref1.01(0.96,1.06) 1.09(1.03,1.16) ref.
Location of HFUrban / Semi-urban / Rural6,171 / 561 / 19179.5 / 80.7 / 85.9ref 1.00(0.96,1.06) 1.09(0.99,1.19) 9,738 / 2,150 / 7,23089.0 / 95.2 / 92.1ref. 1.1(1.01,1.14)^ 1.04(0.97,1.11)ref. 1.1(1.01,1.14)^ 1.04(0.97,1.11)
Type of HFPrimary/ Secondary/ Tertiary/ Private2,619 / 2,647 / 649/ 1,00883.5 / 75.4 / 78.9/ 82.3ref. 0.9(0.86,0.93)^ 0.94(0.9,0.99)^ 0.99(0.94,1.04)ref. 0.9(0.85,0.93)^ 0.95(0.9,1.0)^ 1.0(0.95,1.04)6,778 / 2,462 / 3,364 / 6,51492.4 / 94.2 / 83.6 / 91.9ref. 1.01(0.70,1.06) 0.9(0.80,0.99)^ 0.99(0.94,1.03)ref. 0.99(0.95,1.03) 0.9(0.79,1.0)^ 0.98(0.92,1.04)
Time (in quarters)   2.5(1.6,3.4)%*^2.6(1.7,3.6)%*^  -0.4(-1.1,0.3)%*-0.4(-1.1,0.3)%*
Notes: Adj. RR=adjusted relative risk ratios from a MV model. *tranferred into % change;^p<0.05
[Table 1: 12-month retention among ART patients in ICAP supported HIV care & treatment facilities in Cote d?Ivoire and Swaziland, Jan 2014 ? Sept 2015]

Download the e-Poster